Pankaj Gupta
Distinguished in Meibomianitis

Dr. Pankaj Gupta

Ophthalmology
Mercy Health
Spectrum Eye Care, Inc.
15840 Medical Drive South, Suite A, 
Findlay, OH 
On Staff At
Accepting New Patients
Distinguished in Meibomianitis
Mercy Health
Spectrum Eye Care, Inc.
15840 Medical Drive South, Suite A, 
Findlay, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Pankaj Gupta is an Ophthalmologist in Findlay, Ohio. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Meibomianitis. His top areas of expertise are Meibomianitis, Dry Eye Syndrome, Cataract, Scleritis, and Cataract Removal. Dr. Gupta is currently accepting new patients.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Ohio State University College Of Medicine, 2002
Residency
Cleveland Clinic Graduate Medical Education, Ophthalmology, 2006
Specialties
Ophthalmology
Licenses
Ophthalmology in MA
Board Certifications
American Board Of Ophthalmology
Fellowships
Massachusetts Eye And Ear Infirmary, Ophthalmologic Surgery, 2008
Hospital Affiliations
Mercy Health - St. Rita's Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetLife
  • PPO
Ohio Health Group
  • PPO
SummaCare
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Spectrum Eye Care, Inc.
15840 Medical Drive South, Suite A, Findlay, OH 45840
Call: 419-422-6190
Other Locations
Spectrum Eye Care Inc
Lima, OH 45805
Call: 419-991-3937

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: July 17, 2025
Intervention Type: Other, Drug
Study Drug: Naloxegol
Study Phase: Phase 2
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug
Study Drug: Rucaparib
Study Phase: Phase 2
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Enrollment Status: Completed
Publish Date: March 07, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Docetaxel, Gemcitabine, Gemcitabine Hydrochloride, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Ramucirumab
Study Phase: Phase 2
A Phase III Randomized Trial of Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus (HBV) Infection Receiving Anti-Cancer Therapy for Solid Tumors
A Phase III Randomized Trial of Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus (HBV) Infection Receiving Anti-Cancer Therapy for Solid Tumors
Enrollment Status: Terminated
Publish Date: May 20, 2024
Intervention Type: Drug, Other
Study Drug: Tenofovir Alafenamide
Study Phase: Phase 3
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Device
Study Phase: Phase 1/Phase 2
View 13 Less Clinical Trials

8 Total Publications

Impact of physical and chemical parameters on square wave anodic stripping voltammetry for trace Pb2+ detection in water.
Impact of physical and chemical parameters on square wave anodic stripping voltammetry for trace Pb2+ detection in water.
Journal: The Analyst
Published: July 07, 2022
View All 8 Publications
Similar Doctors
Distinguished in Meibomianitis
Dr. Stephen H. Orr
Ophthalmology
Distinguished in Meibomianitis
Dr. Stephen H. Orr
Ophthalmology

Spectrum Eye Care, Inc.

15840 Medical Drive South, Suite A, 
Findlay, OH 
 (4.6 miles away)
419-422-6190
Languages Spoken:
English
See accepted insurances

Stephen Orr is an Ophthalmologist in Findlay, Ohio. Dr. Orr is rated as a Distinguished provider by MediFind in the treatment of Meibomianitis. His top areas of expertise are Glaucoma, Cataract, Dry Eye Syndrome, and Meibomianitis.

Advanced in Meibomianitis
Dr. Krysta N. Beshaler
Ophthalmology
Advanced in Meibomianitis
Dr. Krysta N. Beshaler
Ophthalmology

Ohio Eye Surgeons Inc

466 S Trimble Rd, Suite B, 
Mansfield, OH 
 (57.6 miles away)
419-756-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Krysta Beshaler is an Ophthalmologist in Mansfield, Ohio. Dr. Beshaler is rated as an Advanced provider by MediFind in the treatment of Meibomianitis. Her top areas of expertise are Cataract, Meibomianitis, Astigmatism, and Glaucoma. Dr. Beshaler is currently accepting new patients.

Advanced in Meibomianitis
Dr. Alison M. Early
Ophthalmology
Advanced in Meibomianitis
Dr. Alison M. Early
Ophthalmology

Pajka Eye Center, Inc

855 West Market Street, 
Lima, OH 
 (38.4 miles away)
419-228-7432
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alison Early is an Ophthalmologist in Lima, Ohio. Dr. Early is rated as an Advanced provider by MediFind in the treatment of Meibomianitis. Her top areas of expertise are Cataract, Meibomianitis, Dry Eye Syndrome, and Gyrate Atrophy of the Choroid and Retina. Dr. Early is currently accepting new patients.

VIEW MORE MEIBOMIANITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
    • Distinguished
    • Cataract
      Dr. Gupta is
      Distinguished
      . Learn about Cataract.
      See more Cataract experts
    • Dry Eye Syndrome
      Dr. Gupta is
      Distinguished
      . Learn about Dry Eye Syndrome.
      See more Dry Eye Syndrome experts
    • Meibomianitis
      Dr. Gupta is
      Distinguished
      . Learn about Meibomianitis.
      See more Meibomianitis experts
    • Advanced
    • Blepharitis
      Dr. Gupta is
      Advanced
      . Learn about Blepharitis.
      See more Blepharitis experts
    • Cicatricial Pemphigoid
      Dr. Gupta is
      Advanced
      . Learn about Cicatricial Pemphigoid.
      See more Cicatricial Pemphigoid experts
    • Cloudy Cornea
      Dr. Gupta is
      Advanced
      . Learn about Cloudy Cornea.
      See more Cloudy Cornea experts
    • Corneal Dystrophy and Perceptive Deafness
      Dr. Gupta is
      Advanced
      . Learn about Corneal Dystrophy and Perceptive Deafness.
      See more Corneal Dystrophy and Perceptive Deafness experts
    • Fuchs Dystrophy
      Dr. Gupta is
      Advanced
      . Learn about Fuchs Dystrophy.
      See more Fuchs Dystrophy experts
    • Glaucoma
      Dr. Gupta is
      Advanced
      . Learn about Glaucoma.
      See more Glaucoma experts
    View All 11 Advanced Conditions
    • Experienced
    • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
      Dr. Gupta is
      Experienced
      . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
      See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
    • Age-Related Macular Degeneration (ARMD)
      Dr. Gupta is
      Experienced
      . Learn about Age-Related Macular Degeneration (ARMD).
      See more Age-Related Macular Degeneration (ARMD) experts
    • Allergic Conjunctivitis
      Dr. Gupta is
      Experienced
      . Learn about Allergic Conjunctivitis.
      See more Allergic Conjunctivitis experts
    • Astigmatism
      Dr. Gupta is
      Experienced
      . Learn about Astigmatism.
      See more Astigmatism experts
    • Bell's Palsy
      Dr. Gupta is
      Experienced
      . Learn about Bell's Palsy.
      See more Bell's Palsy experts
    • Cataract Removal
      Dr. Gupta is
      Experienced
      . Learn about Cataract Removal.
      See more Cataract Removal experts
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.